المؤلفون: Jules Hernández-Sánchez, David G. Kiely, J. Simon R. Gibbs, Joanna Pepke-Zaba, Christopher J. Rhodes, Brian Y.H. Lam, Luke Howard, Richard C. Trembath, Tae-Hwi Schwantes-An, Mark Toshner, John G Coghlan, Paul A. Corris, Amit Arora, Katie A. Lutz, Emily Knightbridge, Colin Church, Stefan Gräf, James Liley, Ken Batai, Marc Humbert, Ankit A. Desai, Louise Harlow, S. John Wort, Sean Gaine, Martin R. Wilkins, William C. Nichols, Rowena Jones, Sofia S Villar Moreschi, Jason H. Karnes, Rick A. Kittles, Lars Harbaum, Dee Gor, Florent Soubrier, Nicholas W. Morrell, Jay Suntharalingam, Michael W. Pauciulo

المصدر: 2022, ' Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension ', The European respiratory journal, vol. 59, no. 3, 2002463 . https://doi.org/10.1183/13993003.02463-2020

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, Male, medicine.medical_specialty, Biomedical Research, Disease, chemistry.chemical_compound, Tocilizumab, Internal medicine, medicine, Humans, Familial Primary Pulmonary Hypertension, Adverse effect, Interleukin 6, Associated Pulmonary Arterial Hypertension, Aged, Pulmonary Arterial Hypertension, biology, business.industry, Interleukin-6, Incidence (epidemiology), Middle Aged, medicine.disease, Connective tissue disease, medicine.anatomical_structure, Treatment Outcome, chemistry, Vascular resistance, biology.protein, Female, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1669f2f7075fc94c5d8cdd8d56ad4951
https://kclpure.kcl.ac.uk/ws/files/170413390/Mendelian_randomisation_and_experimental_TOSHNER_Published_online_10_Mar_22_GOLD_VoR_CC_BY_.pdf